Laurent Roybon, Ph.D

Affiliations: 
Project A.L.S. NY-USA Columbia University, New York, NY 
 Experimental Medical Science Lund University, Lund, Skåne län, Sweden 
Area:
Neurobiology, Stem cells
Website:
http://www.med.lu.se/expmed/stem_cell_laboratory_for_cns_disease_modeling/team
Google:
"Laurent Roybon"
Mean distance: 14.62 (cluster 32)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Chumarina M, Russ K, Azevedo C, et al. (2019) Cellular alterations identified in pluripotent stem cell-derived midbrain spheroids generated from a female patient with progressive external ophthalmoplegia and parkinsonism who carries a novel variation (p.Q811R) in the POLG1 gene. Acta Neuropathologica Communications. 7: 208
Oksanen M, Hyötyläinen I, Trontti K, et al. (2019) NF-E2-related factor 2 activation boosts antioxidant defenses and ameliorates inflammatory and amyloid properties in human Presenilin-1 mutated Alzheimer's disease astrocytes. Glia
Bogetofte H, Jensen P, Ryding M, et al. (2019) Mutation Causes Metabolic Disturbances and Impaired Survival of Human iPSC-Derived Neurons. Frontiers in Cellular Neuroscience. 13: 297
Savchenko E, Teku GN, Boza-Serrano A, et al. (2019) FGF family members differentially regulate maturation and proliferation of stem cell-derived astrocytes. Scientific Reports. 9: 9610
Gustavsson N, Marote A, Pomeshchik Y, et al. (2018) Generation of an induced pluripotent stem cell line (CSC-46) from a patient with Parkinson's disease carrying a novel p.R301C mutation in the GBA gene. Stem Cell Research. 34: 101373
Marote A, Pomeshchik Y, Collin A, et al. (2018) Generation of an induced pluripotent stem cell line (CSC-41) from a Parkinson's disease patient carrying a p.G2019S mutation in the LRRK2 gene. Stem Cell Research. 28: 44-47
Marote A, Pomeshchik Y, Goldwurm S, et al. (2018) Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C>T and EX6 del) in the PARK2 gene. Stem Cell Research. 27: 90-94
Marote A, Pomeshchik Y, Goldwurm S, et al. (2018) Generation of an integration-free induced pluripotent stem cell line (CSC-43J) from a patient with sporadic Parkinson's disease. Stem Cell Research. 27: 82-85
Savchenko E, Marote A, Russ K, et al. (2018) Generation of a human induced pluripotent stem cell line (CSC-42) from a patient with sporadic form of Parkinson's disease. Stem Cell Research. 27: 78-81
Russ K, Marote A, Savchenko E, et al. (2018) Generation of a human induced pluripotent stem cell line (CSC-40) from a Parkinson's disease patient with a PINK1 p.Q456X mutation. Stem Cell Research. 27: 61-64
See more...